CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
We have now added a new section called the "Assay History List" to the "At A Gla...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...